Attention Deficit-Hyperactivity Disorder
What's New
Last Posted: Jan 31, 2023
- Exploring telediagnostic procedures in child neuropsychiatry: addressing ADHD diagnosis and autism symptoms through supervised machine learning.
Silvia Grazioli et al. European child & adolescent psychiatry 2023 1-11 - Association of Potentially Damaging De Novo Gene Variants With Neurologic Outcomes in Congenital Heart Disease.
Sarah U Morton et al. JAMA network open 2023 6(1) e2253191 - Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review.
Cortese Samuele et al. World psychiatry : official journal of the World Psychiatric Association (WPA) 2023 22(1) 129-149 - Family coaggregation of type 1 diabetes mellitus, major depressive disorder, attention-deficiency hyperactivity disorder and autism spectrum disorder in affected families: a nationwide study.
Hsu Tien-Wei et al. Acta diabetologica 2023 - Assessing machine learning for fair prediction of ADHD in school pupils using a retrospective cohort study of linked education and healthcare data.
Ter-Minassian Lucile et al. BMJ open 2022 12(12) e058058 - Findings of a Multidisciplinary Assessment of Children Referred for Possible Neurodevelopmental Disorders: Insights from a Retrospective Chart Review Study.
Alenezi Shuliweeh et al. Behavioral sciences (Basel, Switzerland) 2022 12(12) - Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study.
Coombes Brandon J et al. Complex psychiatry 2022 7(3-4) 80-89 - Machine learning models effectively distinguish attention-deficit/hyperactivity disorder using event-related potentials.
Ghasemi Elham et al. Cognitive neurodynamics 2022 16(6) 1335-1349 - Predicting efficacy of viloxazine extended-release treatment in adults with ADHD using an early change in ADHD symptoms: Machine learning Post Hoc analysis of a phase 3 clinical trial.
Faraone Stephen V et al. Psychiatry research 2022 318114922 - Association between Gut Microbiota and Emotional-Behavioral Symptoms in Children with Attention-Deficit/Hyperactivity Disorder
MJ Lee et al, J Per Medicine, September 29, 2022
More
About ND PHGKB
Neurological Disorders (ND) PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to neurological disorders....more
Content Summary
- CDC Information (6)
- COVID-19 (10)
- Human Genome Epidemiologic Studies (1073)
- GWAS Studies (74)
- Human Genomics Translation/Implementation Studies (78)
- Genomic Tests Evidence Synthesis (9)
- Genomic Tests Guidelines (4)
- Tier-Classified Guidelines (1)
- Non-Genomics Precision Health (35)
- Pathogen Advanced Molecular Detection (1)
- State Public Health Genomics Programs (1)
- Reviews/Commentaries (32)
- Tools/Methods (1)
Common ND Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: